10x Genomics TXG 深 沪
等待开盘 02-06 09:30:00 美东时间
17.90
-1.160
-6.09%
华盛通- 最 高19.36
- 今 开18.67
- 成交量 261.75万股
- 最 低 17.37
- 昨 收 19.06
- 总市值 22.73亿
- 52周最高 23.56
- 市盈率 静 --
- 换手率 2.06%
- 52周最低 6.78
- 委 比 -80.38%
- 总股本 1.27亿
- 历史最高 208.99
- 量 比 1.09
- 振 幅 10.44%
- 历史最低 6.78
- 每 手 1
- 风险率 3.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Breaking Down 10x Genomics: 13 Analysts Share Their Views
10x Genomics (NASDAQ:TXG) underwent analysis by 13 analysts in the last quarter...
01-28 05:01
Cathie Wood's weekly recap: buys WeRide, crypto names, trims defense firm Kratos, PINS, META
Cathie Wood’s ARK Invest broadly rotated its portfolios toward AI, autonomous driving, semiconductors, and crypto infrastructure names last week, while cutting exposure to defense, genomics, and softw...
01-27 19:15
Okta Appoints Rebecca Port as Chief People Officer
Okta Appoints Rebecca Port as Chief People Officer Okta Inc. has appointed Rebecca "Becks" Port as its new Chief People Officer. Port, who previously held leadership roles at Sequoia, 10x Genomics, Netflix, and Standard Chartered Bank, will lead Okta's global people strategy as the company focuses o
01-27 01:02
Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning?
Cathie Wood's Ark Invest unveiled its "big ideas" for 2025 in a cryptic list, challenging users to interpret a series of custom images called "ARKmoji" to understand their picks for the year.
01-20 13:05
Cathie Wood's weekly update: buys Broadcom, AMD; sells Tesla, Illumina
Cathie Wood’s ARK Invest (ARKK) deepened investment in AI chipmakers, gene-editing companies, and autonomous-driving developers while continuing to trim positions in Tesla (TSLA) and several mature te...
01-19 20:35
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
CareDx and 10x Genomics Launch 'ImmuneScape' to Solve the Mystery of Organ Rejection
CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
01-07 20:16
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will pres...
2025-12-30 05:05
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $20
Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $19 to $20.
2025-12-22 21:01
